製品名:1-Fluoro-2-methyl-4-nitrobenzene

IUPAC Name:1-fluoro-2-methyl-4-nitrobenzene

CAS番号:455-88-9
分子式:C7H6FNO2
純度:95%+
カタログ番号:CM253045
分子量:155.13

包装単位 有効在庫 価格(USD) 数量
CM253045-500g in stock ƞƞȀ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:455-88-9
分子式:C7H6FNO2
融点:-
SMILESコード:O=[N+](C1=CC=C(F)C(C)=C1)[O-]
密度:
カタログ番号:CM253045
分子量:155.13
沸点:223°C at 760 mmHg
MDL番号:MFCD00007284
保管方法:Store at 2-8°C.

Category Infos

Benzenes
Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.

Column Infos

Zongertinib
Boehringer’s zongertinib shows encouraging efficacy and tolerability profile in previously treated HER2 mutated lung cancer patients.
Zongertinib (also known as BI 1810631) is an investigational oral HER2-specific tyrosine kinase inhibitor (TKI) that is being developed as a potential treatment for HER2 mutated non-small cell lung cancer (NSCLC). Zongertinib was granted FDA Fast Track Designation in 2023, then in 2024 it was granted Breakthrough Therapy Designation by the U.S. FDA and China CDE for the treatment of adult patients with advanced NSCLC whose tumors have activating HER2 mutations, and who have received a prior systemic therapy.